tradingkey.logo
๎™

AxoGen Inc

AXGN
31.980USD
+0.280+0.88%
์ข…๊ฐ€ย 12/19, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
1.47B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ AxoGen Inc ํšŒ์‚ฌ

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ AXGN
ํšŒ์‚ฌ ์ด๋ฆ„AxoGen Inc
์ƒ์žฅ์ผDec 17, 1986
CEODale (Michael Donald)
์ง์› ์ˆ˜451
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒDec 17
์ฃผ์†Œ13631 Progress Blvd.
๋„์‹œALACHUA
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ32615
์ „ํ™”13864626817
์›น์‚ฌ์ดํŠธhttps://www.axogeninc.com/
์ข…๋ชฉ ์ฝ”๋“œ AXGN
์ƒ์žฅ์ผDec 17, 1986
CEODale (Michael Donald)

AxoGen Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
172.26K
+13.50%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+51.11%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+113.10%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
172.26K
+13.50%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+51.11%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+113.10%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

FY2023
FY2022
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
United States
159.01M
0.00%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 15
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 15
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
First Light Asset Management, LLC
12.59%
BlackRock Institutional Trust Company, N.A.
6.89%
The Vanguard Group, Inc.
5.79%
Morgan Stanley & Co. LLC
4.96%
ArrowMark Colorado Holdings, LLC
4.25%
๊ธฐํƒ€
65.53%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
First Light Asset Management, LLC
12.59%
BlackRock Institutional Trust Company, N.A.
6.89%
The Vanguard Group, Inc.
5.79%
Morgan Stanley & Co. LLC
4.96%
ArrowMark Colorado Holdings, LLC
4.25%
๊ธฐํƒ€
65.53%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Investment Advisor/Hedge Fund
40.33%
Investment Advisor
29.37%
Hedge Fund
14.38%
Research Firm
6.35%
Individual Investor
5.37%
Family Office
1.76%
Bank and Trust
0.35%
Pension Fund
0.33%
Sovereign Wealth Fund
0.13%
๊ธฐํƒ€
1.63%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Dec 8
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q4
342
42.08M
97.83%
+8.74K
2025Q3
350
42.06M
101.71%
+627.35K
2025Q2
344
41.40M
98.61%
+1.26M
2025Q1
339
40.15M
93.21%
-2.27M
2024Q4
327
37.35M
99.16%
-1.08M
2024Q3
305
37.98M
92.55%
+3.00M
2024Q2
285
37.71M
96.69%
+1.44M
2024Q1
290
36.54M
95.40%
-4.68M
2023Q4
299
34.97M
92.73%
+437.14K
2023Q3
304
34.60M
92.75%
-2.09M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
First Light Asset Management, LLC
4.53M
9.84%
+55.03K
+1.23%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.10M
6.74%
-26.22K
-0.84%
Jun 30, 2025
The Vanguard Group, Inc.
2.72M
5.92%
+191.79K
+7.58%
Jun 30, 2025
Morgan Stanley & Co. LLC
1.93M
4.2%
+348.58K
+21.98%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
1.63M
3.53%
+34.80K
+2.19%
Jun 30, 2025
Soleus Capital Management, L.P.
1.46M
3.17%
+13.28K
+0.92%
Jun 30, 2025
Wasatch Global Investors Inc
1.43M
3.12%
+659.15K
+85.09%
Jun 30, 2025
Balyasny Asset Management LP
1.93M
4.2%
+1.25M
+183.91%
Jun 30, 2025
Assenagon Asset Management S.A.
1.29M
2.8%
+265.95K
+25.99%
Sep 30, 2025
Armistice Capital LLC
1.11M
2.42%
+573.04K
+106.46%
Jun 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
ROBO Global Healthcare Technology & Innovation ETF
3.51%
State Street SPDR S&P Health Care Equipment ETF
2.3%
iShares Neuroscience and Healthcare ETF
2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
0.97%
Invesco NASDAQ Future Gen 200 ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
iShares Micro-Cap ETF
0.19%
Fidelity Enhanced Small Cap ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Franklin US Small Cap Multifactor Index ETF
0.14%
๋” ๋ณด๊ธฐ
ROBO Global Healthcare Technology & Innovation ETF
๋น„์œจ3.51%
State Street SPDR S&P Health Care Equipment ETF
๋น„์œจ2.3%
iShares Neuroscience and Healthcare ETF
๋น„์œจ2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
๋น„์œจ0.97%
Invesco NASDAQ Future Gen 200 ETF
๋น„์œจ0.74%
JPMorgan Fundamental Data Science Small Core ETF
๋น„์œจ0.21%
iShares Micro-Cap ETF
๋น„์œจ0.19%
Fidelity Enhanced Small Cap ETF
๋น„์œจ0.18%
Principal U.S. Small-Cap ETF
๋น„์œจ0.15%
Franklin US Small Cap Multifactor Index ETF
๋น„์œจ0.14%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

AxoGen Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
AxoGen Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
First Light Asset Management, LLC๋Š” 4.53M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 9.84%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
BlackRock Institutional Trust Company, N.A.๋Š” 3.10M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 6.74%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
The Vanguard Group, Inc.๋Š” 2.72M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 5.92%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Morgan Stanley & Co. LLC๋Š” 1.93M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 4.20%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
ArrowMark Colorado Holdings, LLC๋Š” 1.63M์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 3.53%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

AxoGen Inc์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
AxoGen Inc์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
First Light Asset Management, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.์ž…๋‹ˆ๋‹ค.

AxoGen Inc(AXGN)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q4 ๊ธฐ์ค€์œผ๋กœ, AxoGen Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 342๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 42.08M๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 97.83%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q3 ๋Œ€๋น„ -3.88% ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

AxoGen Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
FY2023 ๊ธฐ์ค€, AxoGen Inc์˜ -- ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ --๋กœ ์ „์ฒด ๋งค์ถœ์˜ --%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™